News
Resources
Blog
Sites
Guest post: Recognizing National Disability Employment Awareness Month
By Guest Contributor | October 30, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development
By Tom Wilbur | October 28, 2020
America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient access...
Read More
Coming together to fight COVID-19: A conversation with Peter Anastasiou, Executive Vice President of Lundbeck
By Stephen J. Ubl | October 28, 2020
This year, our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections.
Read More
Safe drug disposal: National Prescription Drug Take Back Days and other year-round opportunities
By Guest Contributor | October 23, 2020
The Pharmaceutical Product Stewardship Work Group (PPSWG) is a non-profit membership association for producers of pharmaceutical products. PPSWG was founded in 2014 to organize and facilitate...
Read More
Three things you should know about recent health care polling
By Priscilla VanderVeer | October 23, 2020
Pollsters have been busy this year tracking public sentiment around the top issues of concern for voters. Recent public polling shows that voters priorities have shifted dramatically over the course...
Read More
340B hospitals and for-profit pharmacies generating significant revenue from program meant to help needy patients
By Nicole Longo | October 23, 2020
The 340B program – a safety-net federal drug program meant to help vulnerable Americans – has become dominated by many large hospitals and for-profit corporations with no clear evidence they are...
Read More
Study: Hospital and outpatient care are biggest drivers of health care spending differences between the United States and other countries
By Gabby Migliara | October 22, 2020
A number of past analyses have shown that hospitals drive U.S. health care spending. In fact, data released last year showed that the United States spends three times more per person on hospital care...
Read More
How does Medicare Part D impact you?
By Tom Wilbur | October 21, 2020
Whether you are a direct beneficiary, a caregiver or simply an American taxpayer, Medicare Part D impacts you. The Medicare Part D program, which was created by the Medicare Modernization Act (MMA)...
Read More
Study finds biopharmaceutical innovation is responsible for 35% of the increase in life expectancy from 1990 to 2015
By Gabby Migliara | October 21, 2020
Medicines are responsible for more than a third of the improvement in life expectancy from 1990 to 2015, according to a recent study published in Health Affairs. This underscores the crucial role of...
Read More
Survey found insurance premiums grew faster than inflation in 2020
By Gabby Migliara | October 20, 2020
According to Kaiser Family Foundation’s recent survey on employer health benefits, premiums for people with employer-sponsored health insurance increased by 4% last year, faster than both the rate of...
Read More
Open Enrollment: How to find a Medicare plan that meets your needs
By Tom Wilbur | October 14, 2020
Medicare’s annual open enrollment period is right around the corner. In fact, beginning October 15 and running through December 7, newly qualified patients and current Medicare beneficiaries may...
Read More
Proposed change to Medicaid line extension definition ignores importance of critical improvements in treatments
By Nicole Longo | October 13, 2020
In comments recently submitted to the administration, PhRMA raised concerns with a number of changes included in the Centers for Medicare & Medicaid Services (CMS) Medicaid proposed rule. Today,...
Read More
Guest Post: Honoring Hispanic Heritage Month by taking action on health equity
By Guest Contributor | October 12, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. Today, we are pleased to welcome...
Read More
New Report: The biopharmaceutical industry’s sustained commitment to inspiring and advancing tomorrow’s STEM workforce
By Abigail Lore | October 12, 2020
America’s biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. The ongoing...
Read More
Flu Season 2020: Why it’s time to talk to your doctor today about getting a flu shot
By Richard Moscicki, M.D. | October 8, 2020
As America’s biopharmaceutical companies work around the clock to combat COVID-19, another virus with deadly consequences is right around the corner. The COVID-19 pandemic has led to more than 7.5...
Read More
The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development
By Tom Wilbur | October 7, 2020
America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient access...
Read More
Growth in 340B program has not translated to improvements for patients
By Nicole Longo | October 5, 2020
Is 340B benefiting the vulnerable, uninsured patients it was designed to help? That’s the most important question policymakers should be asking in any discussion about the 340B program....
Read More
Manufacturing Day 2020: A closer look at the biopharmaceutical industry’s contributions
By Megan Van Etten | October 2, 2020
The first Friday of October marks Manufacturing Day, an annual recognition of the critical role manufacturing industries play in powering innovation and generating jobs and economic growth for...
Read More
Coming together to fight COVID-19: A conversation with Alexander Hardy, CEO of Genentech
By Stephen J. Ubl | October 1, 2020
This year, our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections.
Read More
Three reasons why repealing the Part D non-interference clause is a bad idea
By Tom Wilbur | October 1, 2020
For more than a decade, Medicare Part D has provided seniors affordable and comprehensive prescription drug coverage. Its unique, market-based structure has kept overall Part D program costs far...
Read More
Leading researchers to spotlight the critical role of biopharmaceutical R&D
By Andrew Powaleny | October 1, 2020
Biopharmaceutical researchers are at the heart of a robust American research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world.
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
